The use of biguanides and dipeptidyl peptidase-4 inhibitors has similar effects in diabetics
1. Biguanides and dipeptidyl peptidase-4 (DPP-4) inhibitors show no differences in major cardiac or cerebrovascular events, diabetic complications, or death in the Japanese population. Evidence assessment level: 2 (Good) The…
